No Access
Industry Watch
https://doi.org/10.1142/S0219030304001752Cited by:0 (Source: Crossref)
Abstract
Proteome Systems Develops Ovarian Tumor Detection Kit.
Pharmaxis Closer to Market Aridol.
Acrux Receives Milestone Payment from VIVUS.
Biota Raises Funds from Share Purchase Plan.
GSK's Strategic Investment in China.
Aurobindo Pharma Obtains FDA Approval for Mirtazapine Tablets.
IPA Urges for Prudent Patent Legislation.
Zonegran Shown to Reduce Seizures in Infants.
Takeda Pushes for New Drug Application for Ramelteon.
Takeda Collaborates with Sucampo on Constipation Drug.
Eisai Gains Access to MultiCell's Hepatocyte Technology.
SiMEMS Signs International Agreement to Further Develop Revolutionary DNA Chip.
Keywords:
- Proteome System
- Ovarian Tumor Detection Kit
- Pharmaxis
- Market Aridol
- Acrux
- Milestone Payment
- VIVUS
- Biota
- Share Purchase Plan
- GSK's Strategic Investment
- Aurobindo Pharma
- FDA Approval for Mirtazapine Tablets
- IPA
- Prudent Patent Legislation
- Zonegran
- Seizure
- Takeda
- New Drug Application
- Ramelteon
- Takeda
- Sucampo
- Constipation Drug
- Eisai
- MultiCell's Hepatocyte Technology
- SiMEMS
- International Agreement
- Revolutionary DNA Chip
